ArticleCancers2020

Hypothyroidism is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy.

Masako Shomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.